Bruce F. Wesson

Filings by Bruce F. Wesson span 5 companies, the busiest being Medassets Inc, Acura Pharmaceuticals, Inc and Derma Sciences, Inc. We count 220 filings; the first trade dates from 20 October 2004 and the latest from 2 January 2024.

In open-market terms, that means 29 purchases worth €490k on one side and 132 sales worth €25.2M on the other. On balance, insiders were net sellers of €24.7M. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Other entries cover 13 share grants and 20 option exercises.

In size, the median ticket on the buying side is €6,325.

The newest entry dates from 2 January 2024: an option exercise, in Acura Pharmaceuticals, Inc. The last purchase on record was published on 15 December 2017, which is 3,235 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.